The global digestive & intestinal remedies market size was valued at USD 18.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 3.5% from 2022 to 2028. The market is majorly driven by high demand for over-the-counter products such as zientac, omez, and others. There is an increase in gastrointestinal disorders cases among people. Moreover, increasing cases of inflammatory bowel disease, constipation, irritable bowel syndrome, and gastroesophageal reflux illness are other factors that in turn are boosting market growth over the forecast period.
Digestive medicines are the most common over-the-counter medicines purchased by people. Moreover, physicians recommend the use of these medicines only after minor health issues such as acidity and other digestive problems. But in various other countries, these medicines are sold directly to the patients without prescription as per their rules and regulations.
Due to the COVID-19 pandemic, the sales of digestive and intestinal remedies were reduced globally. Lockdown measures to control the spread of COVID-19 and better hygiene have frozen the spread of seasonal illnesses, which has reduced the sales of over-the-counter medicines. Various pharmaceutical companies have displayed quarterly earnings reports which showed that a decrease in digestive and intestinal remedies has affected their bottom line sales in the market.
Market growth of the digestive and intestinal remedies is driven by the changes in the natural food habits, shifting physical routine, and changing eating habits. The use of various chemicals and synthetically produced food ingredients is increasing. The increasing consumption of processed food products can contribute to gastrointestinal disorders. Moreover, the eating out trend is on the rise across the world which also significantly gives rise to digestive problems and market growth.
With the technological developments and advancements, more people are getting dependent on digital techniques. The increasing use of technology is leading the daily lives to become less labor-intense and eventually leading to more sedentary. This creates a lack of physical activity and increases obesity along with digestive and intestinal health issues.
Digestive and intestinal remedies market growth is significantly restrained by the increasing consumption of probiotics and prebiotics in the diets. These probiotics and prebiotic products keep a healthy gut and can help with digestive problems. Other fermented food products such as kefir, kombucha, sauerkraut, etc. are also gaining popularity as excellent for digestive health. The increasing consumption of these supplementary food products is likely to impact the market growth over the forecast period.
The digestive medicines accounted for the largest revenue share of over 50% in 2021 owing to the increasing demand for these drugs due to rising health issues. The rising aging population is also another key factor driving the segment growth. Moreover, altering lifestyles and diets has also increased the demand for digestive remedies products. Hence, owing to these reasons the segment is estimated to show growth over the estimated period.
The remedies against gastrointestinal complaints segment will register the highest growth at 3.7% from 2022 to 2028 due to its growing cases of gastrointestinal disease. Increasing healthcare expenditure, and growth in the geriatric population are major factors boosting segment growth. The growing burden of gastrointestinal disorders in various countries is also making the market more lucrative.
The offline segment dominated the market with the highest share of 70% in 2021. The demand for digestives & intestinal remedies is rising among customers due to more sustainability offered by these offline stores than any other channel. Hence the segment is projected to show growth during the assessment period.
The online segment is estimated to showcase significant growth of CAGR 3.8% over the forecast period. Digestives & intestinal remedies can be purchased at a low price via online platforms. Such channels can provide various benefits such as coupon benefits and other offers. Moreover, the rising incidence of app-based sellers that are significantly popular is also driving the segment over the forecast period.
North America dominated the digestives & intestinal remedies market and accounted for around 45% revenue share in 2021 due to the growing number of gastrointestinal diseases in this region. Also, the growing geriatric and obese population in this region is expected to drive market growth over the forecast period. Increasing research and development activities along with the presence of key market players are other factors boosting market growth over the forecast period.
The Asia Pacific is expected to witness a CAGR of 4.1% from 2022 to 2028. This can be credited to the increasing demand for digestives & intestinal remedies medicine in this region. The rising prevalence of GI illnesses has led to rising demand for digestives & intestinal remedies types. Hence this region is estimated to show the fastest growth rate over the forecast period.
Leading market players are focussing on innovating new types of digestives & intestinal remedies to meet the increasing demand. Various new players are entering the market due to low entry barriers. The increasing demand for digestives & intestinal remedies offers an opportunity for development in regions with high demand. Some of the prominent players in the global digestive & intestinal remedies market include:
Johnson & Johnson
Procter & Gamble Co
Boehringer Ingelheim GmbH
Reckitt Benckiser Group Plc (RB)
Abbott Laboratories Inc.
Takeda Pharmaceutical Co Ltd
Market size value in 2022
USD 18.5 billion
Revenue forecast in 2028
USD 22.9 billion
CAGR of 3.5% from 2022 to 2028
Base year for estimation
2017 - 2020
2022 - 2028
Revenue in USD million/billion and CAGR from 2022 to 2028
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Type, distribution channel, region
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa
U.S.; Germany; U.K.; France; China; Japan; South Africa; Brazil
Key companies profiled
Bayer Healthcare; Johnson & Johnson; GlaxoSmithKline Plc; Procter & Gamble Co; Sanofi; Boehringer Ingelheim GmbH; Reckitt Benckiser; Group Plc (RB); Abbott Laboratories Inc.; Takeda Pharmaceutical Co Ltd; Menarini Group
|Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options
|Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2028. For this study, Grand View Research has segmented the global digestive & intestinal remedies market report based on type, distribution channel, and region:
Type Outlook (Revenue, USD Million, 2017 - 2028)
Remedies Against Gastrointestinal Complaints
Natural And Synthetic Agents
Distribution Channel Outlook (Revenue, USD Million, 2017 - 2028)
Regional Outlook (Revenue, USD Million, 2017 - 2028)
Central & South America
Middle East & Africa
b. The global digestives & intestinal remedies market size was estimated at USD 18.0 billion in 2021 and is expected to reach USD 18.5 billion in 2022.
b. The global digestives & intestinal remedies market is expected to grow at a compound annual growth rate of 3.5% from 2022 to 2028 to reach USD 22.9 billion by 2028.
b. North America dominated the digestives & intestinal remedies market with a share of 44.7% in 2021. This is attributable to higher obese population, awareness about the over the counter medicine, and strong presence and distribution network of the key players.
b. Some key players operating in the digestives & intestinal remedies market include Bayer Healthcare; Johnson & Johnson; GlaxoSmithKline Plc; Procter & Gamble Co; Sanofi; Boehringer Ingelheim GmbH; Reckitt Benckiser; Group Plc (RB); Abbott Laboratories Inc.; Takeda Pharmaceutical Co Ltd; and Menarini Group.
b. Key factors that are driving the digestives & intestinal remedies market growth include increasing sedentary lifestyle, rising eating out trend and increasing consumption of fast food.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."